SERUM LEVEL AND URINARY-EXCRETION OF THIAMAZOL-C-14 IN PATIENTS WITH HYPERTHYROIDISM

被引：7

作者：

BALZER, J

LAHRTZ, H

VANZWIETEN, PA

机构：

[1] UNIV KIEL,MED KLIN 2 & POLIKLIN,METZ STR 53-57,23 KIEL,FED REP GER

[2] UNIV AMSTERDAM,LAB BIOFARM,ROETERS STR 1,AMSTERDAM,NETHERLANDS

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1975年 / 100卷 / 11期

关键词：

D O I：

10.1055/s-0028-1106254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：548 / 552

页数：5

共 7 条

[1] METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].

ALEXANDER, WD ;

EVANS, V ;

MACAULAY, A ;

GALLAGHER, TF ;

LONDONO, J .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+

[2] EFFECT OF HYPERTHYROIDISM ON RENAL CONCENTRATING MECHANISM IN HUMANS [J].

CUTLER, RE ;

GLATTE, H ;

DOWLING, JT .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (04) :453-+

[3]

DOST-ASTI, 2020, PHILS

[4]

LAHRTZ H, 1969, Pharmacologia Clinica, V1, P114, DOI 10.1007/BF00404656

[5] CONCENTRATION OF S-35-PROPYLTHIOURACIL BY THYROID GLAND AND ITS RELATIONSHIP TO ANION TRAPPING MECHANISM [J].

MARCHANT, B ;

ALEXANDER, WD ;

ROBERTSON, JW ;

LAZARUS, JH .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1971, 20 (11) :989-+

[6] RELATION BETWEEN LIPID SOLUBILITY OF PHARMACEUTICS AND THEIR PHARMACOKINETIC BEHAVIOR [J].

RAAFLAUB, J .

EXPERIENTIA, 1970, 26 (05) :457-&

[7]

SITAR DS, 1972, J PHARMACOL EXP THER, V183, P440

← 1 →